TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Reported Basic Consolidated EPS Of $-2.1959 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) for the period ended 2015-12-31 was $-2.1959. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-2.1959.

EPS from continuing operations

Coming to basic EPS from continuing operations, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) reported $-2.1959 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-2.1959.

EPS contribution from parent

For the annual period ended 2015-12-31, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) received basic EPS of $-2.1959 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-2.1959.

Basic net EPS

For the annual period ended 2015-12-31, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) reported basic net EPS of $-2.2. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-2.2.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-2.1959. For the quarter ended 2015-12-31, consolidated diluted EPS was $-2.1959.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-2.1959 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-2.1959.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-2.2. For the quarterly period ended 2015-12-31, net diluted EPS was $-2.2.

Diluted EPS from parent

From the parent company, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) received diluted EPS of $-2.1959 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-2.1959.

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) posted net basic EPS reading of $-2.2 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-2.2 was for the quarter ended 2015-12-31.

Net diluted EPS for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) for the annual period ended 2015-12-31 was $-2.2. The company also reported net diluted EPS reading of $-2.2 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 11.116 while for the quarter ended 2015-12-31 is 11.116.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 11.116 while for the quarter ended 2015-12-31 is 11.116.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)